Screening for Hepatitis C Virus: A Systematic Review
Publisher: Canadian Agency for Drugs and Technologies in Health 2017
Number of pages: 206
The objectives are: (1) to assess the published research evidence on the clinical effectiveness, harms, cost-effectiveness, and associated patients' preferences and values of screening for hepatitis C virus (HCV) infection in asymptomatic, non-pregnant, treatment-naive adults; and (2) to assess the published research evidence on the ability of available antibody (Ab) and antigen (Ag) screening tests to identify people in the general population with chronic HCV infection.
Home page url
Download or read it online for free here:
by Cernescu, Ruta, Gheorghe, Iacob, Popescu, Wanless - Flying Publisher
Chronic hepatitis C is associated with substantial morbidity. This guide presents alternative treatment options to improve the results of current therapies. It demonstrates why doing nothing for non-responders is not an option.
by Seng-Lai Tan - Taylor & Francis
The HCV genome and life cycle, the HCV core protein, glycoproteins, protease and serine protease, helicase, regulator proteins, replicon systems, regulation of host defense and adaptive immunity, vaccine design, and cell culture systems.
by Gaetano Serviddio - InTech
Written by a team of experts daily facing clinical problems in the prevention and management of liver diseases and designed for a global readership to offer some practical tips to physicians who want update their level of practice in the field.
by Roger Chou, et al. - Agency for Healthcare Research and Quality
This report focuses on developing and prioritizing the most pressing research needs around antiviral treatment of hepatitis C virus (HCV) infection in adults. Intended to inform and support researchers and those who fund research.